Table IV.
Scenario | ||||||
---|---|---|---|---|---|---|
Design specifications | 1 | 2 | 3 | 4 | 5 | 6 |
Proportion stopped for safety | ||||||
, ψ = 0, nR = 20 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.721 |
, ψ = −2.049, nR = 20 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.714 |
, ψ = 0.814, nR = 20 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.733 |
, ψ = 0, nR = 20 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.722 |
, ψ = 0, nR = 10 | 0.000 | 0.000 | 0.000 | 0.000 | 0.001 | 0.684 |
, ψ = 0, nR = 30 | 0.000 | 0.000 | 0.000 | 0.000 | 0.001 | 0.701 |
Proportion stopped for futility | ||||||
, ψ = 0, nR = 20 | 0.049 | 0.055 | 0.025 | 0.013 | 0.017 | 0.000 |
, ψ = −2.049, nR = 20 | 0.040 | 0.053 | 0.031 | 0.023 | 0.032 | 0.000 |
, ψ = 0.814, nR = 20 | 0.043 | 0.037 | 0.030 | 0.011 | 0.025 | 0.000 |
, ψ = 0, nR = 20 | 0.073 | 0.095 | 0.046 | 0.022 | 0.057 | 0.000 |
, ψ = 0, nR = 10 | 0.052 | 0.070 | 0.027 | 0.018 | 0.035 | 0.000 |
, ψ = 0, nR = 30 | 0.030 | 0.023 | 0.010 | 0.010 | 0.022 | 0.000 |
Observed DLT rate | ||||||
, ψ = 0, nR = 20 | 0.116 | 0.177 | 0.212 | 0.245 | 0.248 | 0.512 |
, ψ = −2.049, nR = 20 | 0.113 | 0.175 | 0.211 | 0.249 | 0.247 | 0.511 |
, ψ = 0.814, nR = 20 | 0.115 | 0.174 | 0.211 | 0.244 | 0.247 | 0.516 |
, ψ = 0, nR = 20 | 0.118 | 0.175 | 0.214 | 0.241 | 0.242 | 0.508 |
, ψ = 0, nR = 10 | 0.127 | 0.189 | 0.225 | 0.257 | 0.255 | 0.507 |
, ψ = 0, nR = 30 | 0.104 | 0.163 | 0.201 | 0.235 | 0.237 | 0.511 |
Observed response rate | ||||||
, ψ = 0, nR = 20 | 0.256 | 0.272 | 0.340 | 0.411 | 0.399 | 0.508 |
, ψ = −2.049, nR = 20 | 0.256 | 0.271 | 0.342 | 0.411 | 0.402 | 0.503 |
, ψ = 0.814, nR = 20 | 0.259 | 0.267 | 0.343 | 0.419 | 0.400 | 0.509 |
, ψ = 0, nR = 20 | 0.264 | 0.271 | 0.340 | 0.406 | 0.389 | 0.507 |
, ψ = 0, nR = 10 | 0.283 | 0.290 | 0.361 | 0.427 | 0.414 | 0.507 |
, ψ = 0, nR = 30 | 0.230 | 0.251 | 0.323 | 0.399 | 0.381 | 0.510 |
Combinations with acceptable toxicity (i.e., ≤ ϕT = 30%) and high efficacy (i.e., ≥ ϕE = 30%) are defined as ‘target combinations’.